Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-Principle Study of Combination Therapy for Migraine
2004-002605-77Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing GSK fast-dissolving paracetamol + domperidone, Panadol Tablets and Domperidone (3 arms). Primary endpoint: Total pain relief 0-1 hour (TOTPAR0-1 hour). Started Feb 2005; status: completed.
02
Drugs
acetaminophendomperidone
03
Conditions
migraine
Beyond the preview
Go deeper on 2004-002605-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002605-77.